Editas Medicine, Inc. business relationships
Companies named in Editas Medicine, Inc.’s 10-K filed 2026-03-09, and public companies whose annual reports name Editas Medicine, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.9 / 10
- AI naming
- 22 / 100 Top 1% in its category
- Agent readiness
- 0 / 100
- AI adoption
- 0 / 100
Named in Editas Medicine, Inc.’s annual report 2
“In 2018, the Company entered into a license agreement with Beam Therapeutics Inc. ("Beam," and such agreement, the "Beam License Agreement").” SEC filing
“In December 2023, we and Vertex Pharmaceuticals Incorporated ("Vertex") entered into a license agreement (the "Vertex License Agreement"), under which Vertex obtained a non-exclusive license for our Cas9 gene editing technology for ex vivo gene editing medicines targeting the BCL11A gene in the fiel...” SEC filing
Companies whose annual reports name Editas Medicine, Inc. 2
“• Some current collaboration partners include Editas Medicine, Epitopea, Mammoth Biotechnologies and Repair Biotechnologies.” SEC filing
“License agreement with Editas Medicine, Inc.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.